BUZZ-Australia's Arovella Therapeutics jumps on US FDA application for human trials
Reuters
Dec 30, 2025
BUZZ-Australia's <a href="https://laohu8.com/S/ARVEF">Arovella Therapeutics</a> jumps on US FDA application for human trials
** Shares of Arovella TherapeuticsALA.AX jump as much as 10.6% to A$0.084, its biggest intraday pct jump in three months
** Stock hits highest level since Dec 1 after submitting Investigational New Drug $(IND)$ application to U.S. FDA for cell therapy candidate ALA-101
** Co says IND application to progress ALA-101 towards first-in-human Phase 1 clinical trial, pending FDA clearance
** ALA-101 targets specific cancer cells to treat lymphoma and leukemia
** ALA down almost 52% YTD
(Reporting by Aamir Sheik Khalid in Bengaluru)
((Aamir.SheikKhalid@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.